Cefepime is a broad-spectrum antibiotic medication used to treat a variety of bacterial infections. It has been regarded as an effective alternative to other antibiotics in the treatment of certain types of bacterial infections that are resistant to other medications. This article will provide healthcare professionals with an overview of uses, side effects and dosage information for this drug. We will also discuss how Cefepime interacts with other drugs and any special safety measures that need to be taken when prescribing it.
Cefepime is a fourth generation cephalosporin antibiotic. It is used to treat bacterial infections such as pneumonia, bronchitis, and ear, skin, and urinary tract infections. It is also used to treat meningitis. Cefepime has a wide range of activity against Gram-positive and Gram-negative bacteria.
Cefepime is well tolerated with few side effects. The most common side effects are diarrhea, nausea, and vomiting. Cefepime should be used with caution in patients with renal impairment as it is eliminated by the kidneys. The dosage of Cefepime should be reduced in patients with renal impairment.
Cefepime is a safe and effective antibiotic for the treatment of bacterial infections.
Cefepime is a cephalosporin antibiotic used to treat various bacterial infections. It is typically used to treat pneumonia, meningitis, sepsis, and urinary tract infections. Cefepime is generally well-tolerated with few side effects. The most common side effects are nausea, vomiting, diarrhea, and rash.
Cefepime is a fourth-generation cephalosporin antibiotic. It is active against a wide range of Gram-positive and Gram-negative bacteria. Cefepime has good activity against most Enterobacteriaceae, including Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa. It also has excellent activity against Haemophilus influenzae and Moraxella catarrhalis.
The most common side effects of cefepime are diarrhea, nausea, vomiting, headache, and skin rash. Less common side effects include changes in taste, anxiety, insomnia, and seizures. Cefepime may also cause kidney damage.
Cefepime is a powerful antibiotic that is used to treat a variety o bacterial infections. It is well tolerated with few side effects and is generally safe to use. Cefepime should be used with caution in patients with renal impairment as it is eliminated by the kidneys. Healthcare professionals should follow dosage instructions carefully when prescribing cefepime. Cefepime can interact with other medications, so it is important to discuss any other medications the patient may be taking before beginning treatment.f bacterial infections, both in adults and children.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes
2.
A computer-aided diagnostic system for improved detection of breast cancer.
3.
Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.
4.
Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'
5.
According to JAMA, statin use may increase cancer-related survival in breast cancer patients.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
3.
Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes
4.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
5.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation